Trademark: 90377744
Status Date
Monday, October 31, 2022
Filing Date
Saturday, December 12, 2020
Published for Opposition
Tuesday, February 1, 2022
Abandoned Date
Monday, October 31, 2022
5 Mesenchymal stem cells for medical purposes for use in the treatment and prevention of Covid-19 and Coronaviruses; Pharmaceutical preparations for human use, namely, Mesenchymal stem cells for medical or clinical use for the treatment and prevention of Covid-19 and Coronaviruses; Pharmaceutical preparations featuring Mesenchymal stem cells for the treatment and prevention of infectious diseases, namely, COVID-19 and Coronaviruses
Oct 31, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 31, 2022
Abandonment - No Use Statement Filed
Mar 29, 2022
Noa E-Mailed - Sou Required From Applicant
Feb 1, 2022
Official Gazette Publication Confirmation E-Mailed
Feb 1, 2022
Published For Opposition
Jan 12, 2022
Notification Of Notice Of Publication E-Mailed
Dec 29, 2021
Approved For Pub - Principal Register
Nov 5, 2021
Teas/Email Correspondence Entered
Nov 4, 2021
Correspondence Received In Law Office
Nov 4, 2021
Teas Response To Office Action Received
Nov 2, 2021
Teas/Email Correspondence Entered
Nov 1, 2021
Correspondence Received In Law Office
Nov 1, 2021
Teas Response To Office Action Received
May 4, 2021
Notification Of Non-Final Action E-Mailed
May 4, 2021
Non-Final Action E-Mailed
May 4, 2021
Non-Final Action Written
Apr 27, 2021
Assigned To Examiner
Feb 20, 2021
New Application Office Supplied Data Entered In Tram
Dec 16, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24